BeiGene News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.12.24	Biotech Stocks Facing FDA Decision In December 2024 (RTTNews)
27.11.24	EC Approves BeiGene's Tevimbra For First-Line Treatment Of ESCC And G/GEJ Cancer (RTTNews)
21.11.24	Jazz Pharma Gains FDA Accelerated Approval For Ziihera To Treat HER2-positive Biliary Tract Cancer (RTTNews)
28.02.24	Biotech Stocks Facing FDA Decision In March 2024 (RTTNews)
07.02.24	BeiGene's Brukinsa Approved By Health Canada For Treating Follicular Lymphoma (RTTNews)
12.07.23	BeiGene: FDA Accepts SNDA For BRUKINSA In Combination With Obinutuzumab For R/R Follicular Lymphoma (RTTNews)
30.06.23	ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE (PR Newswire)
23.06.23	BGNE LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE (PR Newswire)
15.06.23	Pre-market Movers: EDTX, MVIS, LEJU, SPRB, LAES… (RTTNews)
30.05.23	BeiGene's BRUKINSA Gets Health Canada Approval For CLL Treatment (RTTNews)
27.12.22	Biotech Stocks Facing FDA Decision In January 2023 (RTTNews)
08.12.22	Phanes Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate PT199 in combination with Tislelizumab (PR Newswire)
14.10.22	BeiGene: CHMP Issues Positive Opinion Recommending Approval Of BRUKINSA - Quick Facts (RTTNews)
27.09.22	Pre-market Movers: BKKT, HI, NE, SA, HLX… (RTTNews)
25.08.22	Pre-market Movers: VACC, RVAC, SNOW, FREY, SPLK… (RTTNews)
09.08.22	BeiGene Says Tislelizumab To Treat Hepatocellular Cancer Meets Primary Goal In Late-stage Study (RTTNews)
14.07.22	BeiGene: FDA Defers Action On BLA For Tislelizumab Due To Travel Restrictions (RTTNews)
30.06.22	Novartis: Tislelizumab Plus Chemotherapy Extend Patients' Lives By Median Of More Than Six Months (RTTNews)
28.06.22	Biotech Stocks Facing FDA Decision In July 2022 (RTTNews)
27.06.22	Antengene, BeiGene To Evaluate Selinexor Combination In T And NK-Cell Lymphoma (RTTNews)
24.06.22	Pre-market Movers: TBLT, ZEN, BHAT, GROV, KZIA… (RTTNews)
21.06.22	Pre-market Movers: VALN, GROV, GTIM, BGNE, FEDU… (RTTNews)
25.04.22	Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene (PR Newswire)
15.04.22	BeiGene Reports China NMPA's Approval Of Tislelizumab - Quick Facts (RTTNews)
15.12.21	Pre-market Movers: IDRA, GRTX, SEAC, ALZN, SIDU… (RTTNews)
09.12.21	Direxion Launches mRNA ETF (MSGR) (PR Newswire)
17.09.21	Pre-market Movers: CRVS, ABCL, BGNE, IPHA, IRNT… (RTTNews)
13.09.21	BeiGene : FDA Accepts BLA For Tislelizumab In Esophageal Squamous Cell Carcinoma (RTTNews)
30.08.21	Biotech Stocks Facing FDA Decision In September 2021 (RTTNews)
18.08.21	BeiGene: Swissmedic Begins Formal Review Of MAA For BRUKINSA - Quick Facts (RTTNews)
12.01.21	BGNE Teams Up With NVS, Editas Slumps Over 15%, LLY's Drug Shines In TRAILBLAZER-ALZ, MESO On Watch (RTTNews)
12.01.21	BeiGene Collaborates With Novartis To Develop Cancer Drug; To Receive Up To $1.55 Bln Payments (RTTNews)
13.07.20	Stock Alert: BeiGene Hits New High (RTTNews)
13.07.20	Amgen To Additionally Invest $421 Mln In China's BeiGene (RTTNews)
13.07.20	BeiGene Prices $2.08 Bln Of Registered Direct Offering (RTTNews)
02.01.20	Amgen Completes Purchase Of About $2.8 Bln Of BeiGene Shares (RTTNews)
01.11.19	BGNE Soars, DRNA Hits New High On Roche Deal, FDA Heeds REPH's Request (RTTNews)
31.10.19	Amgen To Acquire 20.5% Stake In BeiGene For Approx. $2.7 Bln - Quick Facts (RTTNews)
27.08.18	BGNE On Watch, AMRN Gears Up For Big Event, ZLAB Discontinues ZL-3101 (RTTNews)
23.07.18	FDA Nod For AGIO's AML Drug, 2nd Neupogen Biosim Gets Green Light, BGNE On Watch (RTTNews)
22.02.18	ANTH Awaits RESULT In Mar., HAIR Grows, NITE Shines, TRXC On Must-watch List (RTTNews)
06.02.18	Xtandi Prospers, One Down, One To Go For AMAG, There's Reason For CORT's Fall (RTTNews)
01.02.18	ZFGN Awaits Data, SLDB Makes Solid Gains, RCKT On Fire, SGEN Snaps Up CASC (RTTNews)
19.01.18	BGNE Up, Up And Away, Data Vindicates CGEN's Strategy, JNCE Awaits ICONIC Data (RTTNews)
10.01.18	LPCN Awaits FDA Panel Vote Today, APHB Slumps, BGNE Crosses $100 Again (RTTNews)
05.12.17	BGNE Well Stocked, APVO On A Roll, GMED Hits ALL-time High (RTTNews)
13.10.17	INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints (RTTNews)
10.10.17	BGNE Hits Record High, SYRS Awaits Catalysts, ALT To Report Data In Q4 (RTTNews)
28.09.17	Gainers & Losers Of Sep.27: ADXS, BGNE, CDXS, VSAR, ITCI... (RTTNews)
07.07.17	Financialinsiders.com Earnings Recap Week Ending July 7th, 2017 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu BeiGene Ltd (spons. ADRs)

Aktien Top/Flop

BeiGene Peer Group Nachrichten

Meistgelesene Nachrichten